Evidence map›Paper›PMID 40500767›Full record

ArticleBiotechnology for biofuels and bioproducts2025

Enhanced co-production of extracellular biopolymers and intracellular lipids by Rhodotorula using lignocellulose hydrolysate and fish oil by-product urea.

Dana Byrtusová, Boris Zimmermann, Achim Kohler, Volha Shapaval

Abstract read
In one paragraph

Article in Biotechnology for biofuels and bioproducts, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dana ByrtusováFaculty of Science and Technology, Norwegian University of Life Sciences, Postbox 5003, 1432, Ås, Norway. dana.byrtusova@nmbu.no.ORCID http://orcid.org/0000-0002-1238-0130
Boris ZimmermannFaculty of Science and Technology, Norwegian University of Life Sciences, Postbox 5003, 1432, Ås, Norway.
Achim KohlerFaculty of Science and Technology, Norwegian University of Life Sciences, Postbox 5003, 1432, Ås, Norway.
Volha ShapavalFaculty of Science and Technology, Norwegian University of Life Sciences, Postbox 5003, 1432, Ås, Norway.

Funding

NordForsk 103506Norges Forskningsråd 301834
6 · The paper itself

Abstract

backgroundA key objective in microbial biorefinery technologies is to identify resilient microorganisms capable of simultaneously synthesizing diverse bioactive metabolites. Among these, Rhodotorula yeasts emerge as promising candidates for converting various waste streams and by-products into high-value chemicals. Their industrial potential stems from their ability to accumulate significant amounts of lipids and carotenoids while also secreting extracellular polymers such as exopolysaccharides, polyol esters of fatty acids, glycolipids, and enzymes-many of which remain to be fully characterized.

resultsAmong the five Rhodotorula strains tested, three exhibited substantial exopolysaccharide production. Notably, Rhodotorula graminis CCY 20-2-47 strain was identified, for the first time, to produce two distinct extracellular biopolymers-exopolysaccharides or polyol esters of fatty acids-depending on the growth conditions. It was observed enhanced production of exopolysaccharides up to 7.2 g L

conclusionsIn conclusion, Rhodotorula yeasts demonstrate significant potential for microbial biorefineries due to their ability to efficiently convert diverse waste substrates into valuable biomaterials, including lipids and extracellular biopolymers. This study provides new insights into a potential metabolic switch in extracellular polymer biosynthesis, driven by Mn

Indexed as

BiomassExtracellular biopolymersLignocelluloseLipidsRenewable substratesRhodotorula

Identifiers

PMID40500767
PMCPMC12153088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.